In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-13 of 13 for your search:
Drug:  tivantinib
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ197-A-U303, NCT01755767

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-009, NCT02029157

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-299, NCT01178411

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: ONC-2011-001, NCT02049060

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00237, CDR0000721410, OSU11132, 8986, N01CM00070, U01CA062491, P30CA016058, N01CM00071, N01CM00100, NCT01519414

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01640, 478834, 12-1359, 9165, N01CM00071, P30CA014599, N01CM00099, N01CM00038, NCT01696955

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00937, 12-2158, 9267, P30CA014599, N01CM00071, NCT01861301

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: ONC-2012-001, NCT01892527

9.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120009, 12-C-0009, NCT01468922

10.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00949, NCI-2012-00974, CO 11914, 9145, P30CA014520, U01CA062491, NCT01625156

11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01220, CDR0000738072, PHI-68, 9152, P30CA033572, U01CA062505, NCT01654965

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 13 months to 21 years
Sponsor: NCI
Protocol IDs: NCI-2012-02163, COG-ADVL1111, ADVL1111, U01CA097452, NCT01725191

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02765, UPCI 12-085, 9153, U01CA099168, P30CA047904, NCT01749384
New Search